Findings
========

Canine atopic dermatitis (AD) is an allergic inflammatory skin disease that is common in West Highland white terriers (WHWTs) \[[@B1]\]. Following a genome-wide association (GWAS) in a group of related WHWTs, we found a 1.3 Mb area on CFA 17 which was significantly associated with the disease \[[@B2]\]. Based on its biological functions, expression patterns and proximity to this area of association, *PTPN22*was selected as a candidate gene for AD in this population. This gene encodes a lymphoid tyrosine phosphatase (PTPN22), a signalling mediator that regulates generic and specialised immune functions in mammals \[[@B3]\]. Activation of T and B lymphocytes is a key event in the pathogenesis of atopic disease \[[@B4]\], and the disruption of these pathways could cause hyper-reactive pathogenic T-cell responses, as well as affect B-cell selection, maturation and function \[[@B5],[@B6]\]. In humans and dogs, genetic variants in the gene *PTPN22*have been associated with auto-immune diseases \[[@B7]-[@B9]\]. In humans, these include psoriasis, a chronic immune-mediated inflammatory skin disease that shares susceptibility loci with human AD \[[@B10],[@B11]\]. To date, no association has been found between *PTPN22*variants and atopic disease in humans \[[@B12]\].

The University of Queensland Animal and Human Ethics Committees, and the University of Sydney Animal Ethics Committee approved this study. Written consent was obtained from all participating dog owners.

Criteria used to classify dogs in the present study are described elsewhere \[[@B1]\]. Fourteen set of primers were designed with primer3 \[[@B13]\], to sequence a total of 12.6 Kb of *PTPN22*in 14 PCR products (Table [1](#T1){ref-type="table"}). Amplification reactions used the HotStar HiFidelity PCR Kit (QIAGEN Pty Ltd, Doncaster, Vic, Australia) and 0.5 μM (PCR products 5 and 12), 1.5 μM (6 and 14) or 1 μM (remaining PCR products) of primers; at 55°C (PCR product 8), 57°C (3 and 14), 58°C (7, 10 and 13), 64°C (5) or 60°C (remaining products) annealing temperatures. PCR products were purified with MinElute PCR Purification Kit (QIAGEN Pty Ltd, Doncaster, Vic, Australia), and bi-directionally sequenced at the Australian Equine Genetics Research Centre using 0.5 μM (PCR product 3, 4, 5, 12, 14) or 1 μM (remaining PCR products) of forward and reverse amplification primers and 0.5 μM of internal sequencing primers (Table [1](#T1){ref-type="table"}), and BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). Primers were supplied by GeneWorks (Hindmarsh, SA, Australia). Sequencing protocol was as recommended by the manufacturer, except annealing temperatures for PCR products 3, 9 and 11 were 50°C and 60°C for PCR products 4 and 5.

###### 

Primer sequences used to amplify and sequence 12.6 Kb of canine *PTPN22*in three atopic and three non-atopic WHWTs

  PCR product   Forward amplification primer   Reverse amplification primer   Internal forward sequencing primer   Internal reverse sequencing primer   Predicted gene region   Product size
  ------------- ------------------------------ ------------------------------ ------------------------------------ ------------------------------------ ----------------------- --------------
  **1**         CCTCATCAGGTGCTCTTCGT           GGTTTTGCCTCTCTCCCTTC           TGAAGTGGAAGAGTCTCAGAGC               AGAAAAGGCAGAAGGCCAGT                 5\'UTR, exon 1          1041
                                                                                                                                                                                
  **2**         GGCTCTGTCCTGAATTGGAG           TCTGCCCTTACCAGGACACT           \-                                   \-                                   Exons 2,3               858
                                                                                                                                                                                
  **3**         CCAAATAAGAGGTCGGGGTA           CTACTGGGAAAATGGGCAAA           AGAAAAGGGAAGGAAGGACA                 TCTGTCCTTCCTTCCCTTTTC                Exons 4,5               863
                                                                                                                                                                                
  **4**         ACCACAGTTGACCTTGGATAA          AGATGAAGGCACATCATGGTC          \-                                   ACATCAAAGGTCCCCTACTCC                Exons 6,7               1182
                                                                                                                                                                                
  **5**         CCACTTGAACTGGTGAAGCA           ACCAGTCCTTCCACAACCAG           \-                                   GGATGGAACCCCATATTGAA                 Exons 8                 1172
                                                                                                                                                                                
  **6**         TGCTCTGGGAAGTAGGGATG           CAAGGCAAGGGACATAGGAA           AATCCACCACAACCAAACCT                 AGCCCGTATTTCCAACTTCC                 Exons 9,10              1267
                                                                                                                                                                                
  **7**         CCGAAATGAGGTAGGCAAAC           GCCCTGTCACTCACCCTTAT           \-                                   \-                                   Exons 11                483
                                                                                                                                                                                
  **8**         TGGAAACTCACCTCTTTTGTGA         TTCTTTGAGAAGGAAAAGGAAGAA       CAGAGTGGGAGACAAAAGCA                 CCAGCTCCTTGGTGTCTCTC                 Exons 12,13             1296
                                                                                                                                                                                
  **9**         GAAGCAGCAGAAAACCTCCTA          ACCCCACATCCTCTAGCACA           GATCCCCATTTGCATTGTTC                 TGGCCCAATTCTTAGGAGTGT                Exons 14,15             889
                                                                                                                                                                                
  **10**        GGGTAAAGGATGCGTTTTCA           TGGGAGCTATTATGGGAACC           \-                                   \-                                   Exons 16                332
                                                                                                                                                                                
  **11**        TGAGGCTCCAGTTATGGTTCA          CAGTCTTGTTCTCAATCTGCTTC        AAGTGGGACCTAAATGGAAAAG               CCTTTTCCATTTAGGTCCCACT               Exons 17,18             747
                                                                                                                                                                                
  **12**        GGATGGGAAAAAGTAGCAAGG          TTCTGATACAAAGAGCCATAGCA        \-                                   \-                                   Exon 19                 410
                                                                                                                                                                                
  **13**        TTCCCTTTAGTGTTGGGCTTT          TTGGCTTTGGCTAGTCACATT          \-                                   \-                                   Exon 20                 92
                                                                                                                                                                                
  **14**        GGCTGAATTACCAAAGGTTGT          TTCACAAATCCATCGTCAGG           TCGCAAAATCTGACTTGTGG                 GGGAGATGTGCAAGGAATTT                 Exon 21, 3\'UTR         550

Sequence data were analyzed with ChromasPro v1.5 (Technylisium, Tewantin, Qld, Australia) and compared with the 1.5× poodle (version 1) and the boxer 7.6× whole-genome sequences (CanFam2.0). Among 18 variants identified \[[@B14]\], five variants showed a medium to high disease-associated risk as predicted by FASTSNP \[[@B15]\] and Mutation Taster \[[@B16]\]; three single-nucleotide polymorphisms (SNPs) in a predicted regulatory region of the gene, one synonymous SNP, and a variable sequence repeat in a predicted splice site (Table [2](#T2){ref-type="table"}). These variants formed five different haplotypes (Table [3](#T3){ref-type="table"}). There were no recombinant events within this 12.6 Kb interval.

###### 

*PTPN22*sequence variants identified by sequencing genomic DNA from three atopic and three non-atopic WHWTs.

  Sequence variant identity   Position on CFA17 (bp)^a,b^   Predicted location in gene   Nucleotide in reference database^b^   Sequence of variant     Reference SNP identity             Predicted functional effect^c^                 Variant risk score ^c^   Atopic dogs       Non-atopic dogs   Cross-species conservation of variant nucleotide sequence^b,d^                                          
  --------------------------- ----------------------------- ---------------------------- ------------------------------------- ----------------------- ---------------------------------- ---------------------------------------------- ------------------------ ----------------- ----------------- ---------------------------------------------------------------- ----------- -------------- ----------- --------------------
                                                                                                                                                                                                                                                                  **Dog 1**         **Dog 2**         **Dog 3**                                                        **Dog 4**   **Dog 5**      **Dog 6**   
                                                                                                                                                                                                                                                                                                                                                                                                              
  [1]{.ul}                    54759173                      UTR                          C                                     T                       rs22597162                         Transcription regulatory (score 86.5)          1-3                      C/C               C/T               C/T                                                              C/C         C/C            C/C         Conserved in 10/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  [2]{.ul}                    54759006                      UTR                          A                                     del                     New variant (dbSNP ss 315790492)   Transcription regulatory (score 87.7)          1-3                      del/del           del/A             del/A                                                            T/A         del/A          A/A         Conserved in 9/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  3                           54742593                      Intronic                     A                                     G                       rs22597162                         NA                                             0-2                      G/G               G/A               G/A                                                              G/G         G/G            G/G         Not conserved
                                                                                                                                                                                                                                                                                                                                                                                                              
  4                           54742027                      Intronic                     A                                     T                       rs22559551                         NA                                             0-2                      T/T               T/A               T/A                                                              A/A         T/A            A/A         Conserved in 6/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  5                           54739568                      Intronic                     T                                     C                       rs22559538                         NA                                             No risk                  T/T               C/T               C/T                                                              C/C         C/T            C/C         Not conserved
                                                                                                                                                                                                                                                                                                                                                                                                              
  6                           54739315                      Intronic                     A                                     G                       New variant (dbSNP ss 315790493)   NA                                             0-2                      G/G               G/G               G/G                                                              A/A         A/G            A/A         Not conserved
                                                                                                                                                                                                                                                                                                                                                                                                              
  7                           54738923                      Intronic                     G                                     del                     New variant (dbSNP ss 15790494)    NA                                             No risk                  del/del           del/del           del/del                                                          del/del     del/del        del/del     NA
                                                                                                                                                                                                                                                                                                                                                                                                              
  8                           54738927                      Intronic                     \-                                    A                       New variant (dbSNP ss 315790495)   NA                                             No risk                  A/A               A/A               A/A                                                              A/A         A/A            A/A         NA
                                                                                                                                                                                                                                                                                                                                                                                                              
  9                           54734456                      Intronic                     T                                     C                       rs22559532                         NA                                             0-2                      C/C               C/T               C/T                                                              C/C         C/C            C/C         Not conserved
                                                                                                                                                                                                                                                                                                                                                                                                              
  10                          54734415                      Intronic                     A                                     G                       rs22559522                         NA                                             No risk                  A/A               A/G               A/G                                                              G/G         A/G            G/G         Conserved in 10/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  [11]{.ul}                   54717953                      Exonic                       G                                     A                       New variant (dbSNP ss 315790496)   Synonymous Splicing regulatory (score 85.4)    1-4                      G/G               G/G               G/G                                                              A/A         A/A            A/A         Conserved in 7/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  12                          54715779                      Intronic                     T                                     C                       rs22578128                         NA                                             0-2                      C/C               C/T               C/T                                                              T/T         C/T            T/T         Conserved in 2/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  [13]{.ul}                   54709793                      Intronic (spice site)        17-T repeat (wild)                    22-T repeat (variant)   New variant (dbSNP ss 315790497)   Alternative splicing regulatory (score 3.39)   3-4                      variant/variant   variant/wild      variant/wild                                                     wild/wild   variant/wild   wild/wild   Conserved in 10/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  14                          54699432                      UTR                          C                                     T                       New variant (dbSNP ss 315790498)   NA                                             0-2                      C/C               C/C               C/C                                                              T/T         T/T            T/T         Not conserved
                                                                                                                                                                                                                                                                                                                                                                                                              
  15                          54698793                      UTR                          G                                     T                       New variant (dbSNP ss 315790499)   NA                                             1-3                      T/T               T/T               T/T                                                              T/T         T/T            T/T         NA
                                                                                                                                                                                                                                                                                                                                                                                                              
  [16]{.ul}                   54698788                      UTR                          C                                     T                       New variant (dbSNP ss 315790500)   Transcription regulatory (score 85.4)          1-3                      T/T               T/T               T/T                                                              C/C         C/C            C/C         Conserved in 7/10
                                                                                                                                                                                                                                                                                                                                                                                                              
  17                          54698729                      UTR                          T                                     C                       New variant (dbSNP ss 315790501)   NA                                             1-3                      C/C               C/C               C/C                                                              C/C         C/C            C/C         NA
                                                                                                                                                                                                                                                                                                                                                                                                              
  18                          54698473                      UTR                          G                                     T                       New variant (dbSNP ss 315790502)   NA                                             0                        T/T               T/T               T/T                                                              G/G         G/T            G/G         Conserved in 9/10

Sequence variants with a predicted medium to high disease-associated functional effect, with strongly conserved sequence across 10 mammals (dog, human, pig, horse, mouse, rat, cattle, chimpanzee, gorilla and orangutan) and differential distribution between atopic and non-atopic dogs are underlined (Sequence variant identities 1, 2, 11, 13 and 16)

^a^reverse strand; ^b^based on the 1.5× poodle genome (version 1) and the boxer 7.6× whole-genome sequences (CanFam2.0), accessed in March 2010 from <http://www.ncbi.nlm.nih.gov> and <http://genome.ucsc.edu>; ^c^as predicted by FASTSNP \[[@B5]\]; disease-risk possibilities are 0 (no potential functional risk), 1 (very low risk), 2 (low risk), 3 (medium), 4 (high risk) and 5 (very high risk); FASTSNP provides a \"risk score\" for each SNP based on its putative biological function; ^d^analyzed following genomic alignment of flanking regions containing the genetic variants in 10 possible species (dog, human, pig, horse, mouse, rat, cattle, chimpanzee, gorilla and orangutan); UTR: untranslated region (DNA); NA: not accessed; del: nucleotide deletion

###### 

Haplotypes constructed using 18 genetic variants of *PTPN22*

  Haplotype^a^   Number of chromosomes                                    
  -------------- -------------------------------------------------- ----- -----
  A              C-del-G-T-T-T-del-A-C-A-C-C-variant^b^-C-T-T-C-T   4/6   0/6
                                                                          
  B              T-A-A-C-C-G-del-A-T-G-C-T-wild^c^-C-T-T-C-T        2/6   0/6
                                                                          
  C              C-A-G-C-C-A-del-A-C-G-T-T-wild^c^-T-T-C-C-T        0/6   4/6
                                                                          
  D              C-A-G-C-C-A-del-A-C-G-T-C-wild^c^-T-T-C-C-G        0/6   1/6
                                                                          
  E              C-del-G-T-T-G-del-A-C-A-C-T-variant^c^-T-T-C-C-T   0/6   1/6

^a^maximum-likelihood (Log likelihood = - 108.87) haplotype assignment for the dogs as predicted by Superlink \[[@B7]\]; ^b^22-T repeat allele; ^c^17-T repeat allele; del: nucleotide deletion

Variant sequence repeat c.2137-20 T(17_22) (Figure [1](#F1){ref-type="fig"}) has not been previously reported in dogs or other species and was bioinformatically predicted to have indirect structural effects on PTPN22. Comparable intronic repeat variations might interfere with normal gene expression \[[@B17]-[@B19]\] and have been associated with alternative splicing and disease in humans \[[@B20]-[@B23]\]. Thus, fluorescently labelled, amplified-fragment length genotyping of this variant was performed in 72 WHWTs, including 54 dogs from the GWAS. Primers and PCR conditions for amplification of PCR product 11 were used. Genotyping was performed on a 3130xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) and analyzed using Genemapper (Applied Biosystems, Foster City, CA, USA). SIB-PAIR \[[@B24]\] showed no significant evidence for allelic association between this variant and the trait (gene-dropping simulation method, *P*= 0.01). Large scale genotyping and complementary genomic and proteomic assays would be required to assess any potential effect of the remaining genetic variants in *PTPN22*.

![**Relative location of the variant sequence repeat c.2137-20 T(17_22) in canine *PTPN22***. Exons in the gene are marked in yellow, variants annotated in web-based databases are in green and the new intronic variant identified by sequencing in three atopic and three non-atopic WHWTs is highlighted in pink. Line numbering is relative to coordinate system.](1756-0500-4-571-1){#F1}
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The data set supporting the results of this article is available in the National Center for Biotechnology Information Reference Assembly dbSNP repository, <http://www.ncbi.nlm.nih.gov/SNP/snp_viewTable.cgi?handle=O_LEARY_ATOPY>.
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